Loading...
Timely insights from the Economy, Strategy & Finance Center
The US administration has issued several executive orders (EOs) related to the nation’s pharmaceutical supply creating a trifecta of challenges for drug companies regarding pricing, onshoring, and tariffs. The most recent EO on May 12 seeks to lower the price of prescription drugs in the US by implementing a “most favored nation” (MFN) pricing requirement.
The order directs the Secretary of Health and Human Services to communicate price targets to pharmaceutical manufacturers within 30 days to bring US drug prices in line with comparably developed nations.
Separately, there is another EO directing the industry to increase US manufacturing and an in-process US Department of Commerce investigation, which is expected to result in tariffs on pharmaceuticals. The confluence of these factors has been called a “worst-case scenario” for the global pharmaceutical industry.
Why it matters: Price increases and supply chain disruptions are increasingly likely
myTCB® Members get exclusive access to webcasts, publications, data and analysis, plus discounts to events.
Fed Signals It May Need to Pause
October 29, 2025
Fed Cut Amid Data Fog: What You Need to Know
October 28, 2025
CPI Details Give Green Light to Further Fed Rate Cuts
October 24, 2025
Rising Inflation Still Leaves Room for Fed Rate Cuts
September 26, 2025
Rising Labor Market Risks Unite the Fed to Deliver 25bps Cut
September 17, 2025
Fed to Cut 25bps to Preserve Delicate Economic Balance
September 16, 2025
Charts
The proliferation of easy-to-use generative AI requires that policymakers and business leaders each play an important role.
LEARN MORE
Charts
A hyperpolarized environment, diminished trust in our nation’s leaders.
LEARN MORE
IN THE NEWS
Denise Dahlhoff on How CEOs Are Talking About Tariffs—without Saying “Tarif…
May 21, 2025
IN THE NEWS
Erin McLaughlin on Tariff Policy
April 07, 2025
IN THE NEWS
Erin McLaughlin on Reshoring Factors
April 05, 2025
IN THE NEWS
Erin McLaughlin on US Reshoring
April 02, 2025
IN THE NEWS
Erin McLaughlin: How policy uncertainty may exacerbate infrastructure chall…
March 19, 2025
IN THE NEWS
Erin McLaughlin discusses the latest on tariff policy
March 14, 2025
Email
Linkedin
Facebook
X
Copy Link
